Product Information
WINLEVI 1% CREAM is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $10.0010 per GM under NDC 47335099436. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Aug 26, 2020.
Strength
1 g/100g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335099436
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLASCOTERONEApproval Type
New Drug (NDA)
FDA Application
NDA213433FDA Approved
8/26/2020
On Market Since
10/4/2021
Pharmacological Classes
Price Statistics
The NADAC for WINLEVI 1% CREAM has been published 237 times since Mar 23, 2022, and over the history we have for it it has risen 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0010 per GM |
|---|---|
| All-time high | $10.0010 (Sep 30, 2026) |
| All-time low | $8.8297 (Mar 23, 2022) |
| 52-week high | $10.0010 |
| 52-week low | $9.7916 |
| Median price | $9.5974 |
| Average price | $9.5176 |
| Largest weekly change | +6.0% (Nov 2, 2022) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clascoterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clascoterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen Receptor Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WINLEVI 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for WINLEVI 1% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $10.0010 per GM (NDC 47335099436), effective Sep 30, 2026.
How has the price of WINLEVI 1% CREAM changed over time?
Over the history we have for it, the NADAC for WINLEVI 1% CREAM has risen 13.3%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for WINLEVI 1% CREAM?
Since Mar 23, 2022, the NADAC for WINLEVI 1% CREAM has ranged from a low of $8.8297 (Mar 23, 2022) to a high of $10.0010 (Sep 30, 2026), with a median of $9.5974 per GM.
Are there cheaper alternatives to WINLEVI 1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of WINLEVI 1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures WINLEVI 1% CREAM?
WINLEVI 1% CREAM (NDC 47335099436) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.